Author

Paula A. Pino

Cornell UniversityORCID 0000-0001-8626-926XUnclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Research Focus:cell type annotation· 1 Organism:mouse· 1

Frequent Co-Authors

Alasdair Smith· 1 shared Alice DawsoniD· 1 shared Amberlee HicksiD· 1 shared Andreu Garcia‐VilanovaiD· 1 shared Andrew J. Fiore-GartlandiD· 1 shared Beatriz BaragañaiD· 1 shared Bhavesh R. BorateiD· 1 shared Billie Maingot· 1 shared

Activity by Year

2025-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

Alasdair Smith

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

ImmunologybioRxivPreprintSep 13, 2025

Identification of protective human monoclonal antibodies using a K18 hACE2 transgenic mouse SARS-CoV-2 challenge model

Bhavesh R. Borate, Paula A. Pino, Amberlee Hicks…·Andrew J. Fiore-Gartland

This study identifies protective human monoclonal antibodies against SARS-CoV-2 using a K18 hACE2 transgenic mouse model, showing that in vivo testing improves accuracy over in vitro assays.

DOI 10.1101/2025.09.13.675985

mouseexperimental assay

𝕏 PostBluesky

MicrobiologyJournal of Medicinal ChemistryPeer-reviewedAug 1, 2025

Design and development of lysyl tRNA synthetase inhibitors, for the treatment of tuberculosis

Susan H. Davis, Michael Mathieson, Kirsteen I. Buchanan…·Laura A. T. Cleghorn

The paper describes the development of lysyl tRNA synthetase inhibitors for tuberculosis treatment, optimizing compounds for preclinical and potential clinical use.

3 citations

experimental assaydrug response / drug discovery

𝕏 PostBluesky